Breast

Breast
2024-12-10T00:32:56.151Z

BGB-43395-101

BGB-43395-101
Breast cancer

A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CDK4 Inhibitor BGB-43395, Alone or as Part of Combination Therapies in Patients With Metastatic HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CDK4 Inhibitor BGB-43395, Alone or as Part of Combination Therapies in Patients With Metastatic HR+/HER2- Breast Cancer and Other Advanced Solid Tumours

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Breast cancer

Study Phase

Ia/Ib

Trial Identifiers
GenesisCare Location(s)
St Andrew's Precinct (Oncology)
location pin icon

Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia

phone icon (08) 8228 6700 email icon infooncologysa@genesiscare.com
SA
St Andrew's Precinct (Oncology)
Principal Investigator(s)
Medical Oncologist

A/Prof Nick Murray

BM MS MA DPhil FRCP(Lon) FRACP

A/Prof Nick Murray
location pin icon

South Terrace (St Andrew’s Medical Centre)

View Profile
Profile Image - A/Prof Nick  Murray

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.